PRESS RELEASE published on 05/17/2023 at 14:00, 3 years 2 months ago XS Financial Announces Date for Q1 2023 Financial Results and Earnings Call
PRESS RELEASE published on 05/16/2023 at 14:00, 3 years 2 months ago XS Financial Expands Into Non-Cannabis Industries and Forms Capital Markets Desk
PRESS RELEASE published on 05/02/2023 at 14:30, 3 years 2 months ago XS Financial Provides a $7.5 Million Capex Lease Facility to Northeast Alternatives Inc
PRESS RELEASE published on 04/25/2023 at 22:00, 3 years 2 months ago XS Financial Reports 2022 Fourth Quarter and Full Year Results
PRESS RELEASE published on 04/17/2023 at 14:30, 3 years 3 months ago XS Financial Announces Date for Year End 2022 Financial Results and Earnings Call
PRESS RELEASE published on 03/30/2023 at 14:15, 3 years 3 months ago XS Financial Announces Changes to Management and Board
PRESS RELEASE published on 03/20/2023 at 13:00, 3 years 4 months ago XS Financial Board and Management Voluntarily Forfeit over 25 Million Options
PRESS RELEASE published on 02/03/2023 at 22:30, 3 years 5 months ago XS Financial Announces Stock Option Issuances
PRESS RELEASE published on 02/01/2023 at 14:00, 3 years 5 months ago XS Financial Posts a Record Year With Over $147 Million in Capex Financing Commitments
PRESS RELEASE published on 01/30/2023 at 14:00, 3 years 5 months ago XS Financial Provides an $8 Million Capex Lease Facility to Aeriz Holdings Corp
Published on 07/22/2026 at 15:00, 15 hours 29 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 15 hours 29 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 15 hours 54 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 15 hours 59 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/23/2026 at 02:05, 4 hours 24 minutes ago JINRO Unveils First Global Campaign "My Favorite JINRO" with V of BTS
Published on 07/22/2026 at 23:58, 6 hours 31 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Increase in 2026 Guidance: EBITDA of approximately EUR 365 million expected
Published on 07/22/2026 at 22:20, 8 hours 9 minutes ago Quantinuum Appoints Chief Legal Officer and Chief People Officer
Published on 07/22/2026 at 21:01, 9 hours 28 minutes ago EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 18:19, 12 hours 10 minutes ago Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 12 hours 44 minutes ago Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:40, 12 hours 49 minutes ago Report on share repurchases from 15 to 21 July 2026
Published on 07/22/2026 at 08:03, 22 hours 26 minutes ago Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:00, 22 hours 29 minutes ago Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy
